Global Coronary Heart Disease Diagnostic Imaging Devices Market Size & Trends Report Segmented by Modality (CT, MRI, X-ray, Nuclear Imaging, Ultrasound), End User (Hospitals, ASCs, Diagnostic Imaging Centers) & Regional Forecast to 2030
The coronary heart disease diagnostic imaging devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving growth include the rising prevalence of coronary heart diseases, growth in the geriatric population, technological advancements in imaging devices, growing demand for non-invasive diagnostic techniques, adoption of sedentary lifestyles worldwide, rising awareness and early diagnosis of coronary heart disease, and increased R&D investments and grants for cardiovascular research. To learn more about the research report, download a sample report.
Report Overview
Coronary Heart Disease (CHD) diagnostic imaging devices are medical technologies designed to generate detailed images of the heart, aiding in the diagnosis of CHD, a condition caused by plaque buildup in the coronary arteries, leading to reduced blood flow. These devices enable healthcare professionals to examine heart structures, evaluate blood circulation, and identify blockages or abnormalities in the coronary arteries. CHD diagnostic imaging technologies include X-ray machines, CT scanners, MRIs, and other advanced imaging systems that provide clear visualization of the heart and blood vessels.
To learn more about this report, download the PDF brochure
Growing demand for non-invasive diagnostic techniques fuels its demand
With continuous technological advancements, non-invasive imaging has become essential not only for diagnosing Coronary Heart Disease (CHD) but also for guiding treatment decisions, assessing prognosis, and optimizing cost-effective, value-based care. Unlike traditional invasive procedures such as catheter-based coronary angiography, which pose risks of complications, extended recovery times, and higher medical expenses, advanced non-invasive imaging techniques including CT Coronary Angiography (CCTA), Cardiac MRI, Echocardiography, and Nuclear Imaging—offer safer, faster, and more precise diagnostic solutions. These modalities provide both functional and anatomical insights into coronary artery blockages, blood flow, and heart function, allowing for accurate disease assessment without surgical intervention. With increasing awareness of early CHD detection, growing healthcare investments, and the expanding use of AI-powered imaging technologies, demand for non-invasive diagnostic imaging is expected to rise significantly, further driving market growth.
Rising prevalence of CHD drives market growth
Coronary Heart Disease (CHD) is the most prevalent cardiovascular disease (CVD), causing nearly 9 million deaths annually, as reported by the World Health Organization (WHO). Its rising incidence is driven by factors such as an aging population, increasing obesity rates, diabetes, and hypertension. Additionally, urbanization and modern lifestyle changes have contributed to higher stress levels, unhealthy diets, and reduced physical activity, further elevating CHD risk. Since CHD often develops silently, with symptoms emerging in later stages, early detection through CHD imaging devices is essential. Accurate and timely diagnosis enables healthcare providers to make well-informed decisions, improving patient care by facilitating the development of optimal treatment plans. Furthermore, CHD imaging devices play a crucial role in monitoring disease progression, assessing treatment effectiveness, and detecting other cardiovascular conditions, fueling their growing demand.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global coronary heart disease diagnostic imaging devices market is marked by the presence of established and emerging market players such as Canon Medical Systems; Esaote SPA; FUJIFILM Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Koninkilijhe Phillips N. V.; SAMSUNG; Siemens Healthineers AG; Ziehm Imaging GmbH; Carestream Health; Shimadzu Corporation; Bracco Imaging S.p.A.; and Hologic, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~7% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Modality and End User |
| Regional Scope |
|
| Key Companies Mapped | Canon Medical Systems; Esaote SPA; FUJIFILM Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Koninkilijhe Phillips N. V.; SAMSUNG; Siemens Healthineers AG; Ziehm Imaging GmbH; Carestream Health; Shimadzu Corporation; Bracco Imaging S.p.A.; and Hologic, Inc. |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Coronary Heart Disease Diagnostic Imaging Devices Market Segmentation
This report by Medi-Tech Insights provides the size of the global coronary heart disease diagnostic imaging devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on modality and end user.
Market Size & Forecast (2023-2030), By Modality, USD Million
- Computed Tomography (CT)
- X rays Angiography (Fluoroscopy)
- Ultrasound (Echocardiography)
- Magnetic Resonance Imaging (MRI)
- Nuclear Imaging (PET & SPECT)
Market Size & Forecast (2023-2030), By End User, USD Million
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Diagnostic Imaging Centers
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the coronary heart disease diagnostic imaging devices market?
- What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the coronary heart disease diagnostic imaging devices market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Coronary Heart Disease Diagnostic Imaging Devices Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of coronary heart diseases
- Technological advancements in imaging devices
- Growing demand for non-invasive diagnostic techniques
- Rising awareness and early diagnosis of coronary heart disease
- Increased R&D investments and grants for cardiovascular research
- Restraints
- High cost of advanced imaging systems
- Shortage of skilled professionals
- Radiation exposure risks & regulatory challenges
- Opportunities
- Rising investment in advanced imaging technologies and AI-driven diagnostics
- Integration of AI and machine learning in imaging
- Development of portable & wearable imaging devices
- Key Market Trends
- Rising preference for non-invasive & hybrid imaging technologies
- Adoption of 3D & 4D imaging
- Expansion of telemedicine and remote diagnostics
- Unmet Market Needs
- Industry Speaks
- Global Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), By Modality, USD Million
- Introduction
- Computed Tomography (CT)
- X rays Angiography (Fluoroscopy)
- Ultrasound (Echocardiography)
- Magnetic Resonance Imaging (MRI)
- Nuclear Imaging (PET & SPECT)
- Global Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Diagnostics Imaging Centers
- Others
- Global Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Coronary Heart Disease Diagnostic Imaging Devices Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Modality (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2024)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Canon Medical Systems
- Esaote SPA
- FUJIFILM Holdings Corporation
- GE Healthcare
- Koninkilijhe Phillips N. V.
- SAMSUNG
- Siemens Healthineers AG
- Ziehm Imaging GmbH
- Bracco Imaging S.p.A.
- Hologic, Inc.
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Imaging Centers, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts.
Data Triangulation
Research findings derived through secondary sources & internal analysis were validated with Primary Interviews, the Internal Knowledge Repository, and the Company’s Sales Data.
